Thrombolytic therapy for myocardial infarction: the problem, the promise and the price.
D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D006801:Humans; D007262:Infusions, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D012008:Recurrence; D013300:Streptokinase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
D013300:Streptokinase; D010959:Tissue Plasminogen Activator